These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 34464604)
1. Rotigotine-loaded microspheres exerts the antinociceptive effect via central dopaminergic system. Li T; Wang L; Zhang L; Li B; Wang D; Zhang L; Wang T; Fu F Eur J Pharmacol; 2021 Nov; 910():174443. PubMed ID: 34464604 [TBL] [Abstract][Full Text] [Related]
2. Antinociceptive effects of rotigotine-loaded microspheres and its synergistic interactions with analgesics in inflammatory pain in rats. Li T; Wang T; Wang L; Liu R; Zhang L; Zhai R; Fu F Eur J Pharmacol; 2021 Jan; 891():173693. PubMed ID: 33160937 [TBL] [Abstract][Full Text] [Related]
3. Protection of MPTP-induced neuroinflammation and neurodegeneration by rotigotine-loaded microspheres. Yu X; Yao JY; He J; Tian JW Life Sci; 2015 Mar; 124():136-43. PubMed ID: 25640758 [TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide/D-galactosamine-induced acute liver injury could be attenuated by dopamine receptor agonist rotigotine via regulating NF-κB signaling pathway. Yue S; Wang T; Yang Y; Fan Y; Zhou L; Li M; Fu F Int Immunopharmacol; 2021 Jul; 96():107798. PubMed ID: 34162160 [TBL] [Abstract][Full Text] [Related]
5. Three-month subchronic intramuscular toxicity study of rotigotine-loaded microspheres in SD rats. Ye L; Guan X; Tian J; Zhang J; Du G; Yu X; Yu P; Cen X; Liu W; Li Y Food Chem Toxicol; 2013 Jun; 56():81-92. PubMed ID: 23454207 [TBL] [Abstract][Full Text] [Related]
6. Preparation of rotigotine-loaded microspheres and their combination use with L-DOPA to modify dyskinesias in 6-OHDA-lesioned rats. Wang A; Wang L; Sun K; Liu W; Sha C; Li Y Pharm Res; 2012 Sep; 29(9):2367-76. PubMed ID: 22549738 [TBL] [Abstract][Full Text] [Related]
7. Dopaminergic mechanisms in periaqueductal gray-mediated antinociception. Tobaldini G; Reis RA; Sardi NF; Lazzarim MK; Tomim DH; Lima MMS; Fischer L Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):225-233. PubMed ID: 29035918 [TBL] [Abstract][Full Text] [Related]
8. In vivo dopamine agonist properties of rotigotine: Role of D1 and D2 receptors. Fenu S; Espa E; Pisanu A; Di Chiara G Eur J Pharmacol; 2016 Oct; 788():183-191. PubMed ID: 27343381 [TBL] [Abstract][Full Text] [Related]
9. Effects of rotigotine and rotigotine extended-release microsphere therapy on myocardial ischemic injury in mice. Lv H; Yu F; Sha C; Huang Y; Lu Y; Zhang L; Zhai R; Wang T; Fu F Eur J Pharm Sci; 2019 Jun; 134():1-6. PubMed ID: 30959104 [TBL] [Abstract][Full Text] [Related]
10. Antinociceptive effect of calcitonin gene-related peptide in the central nucleus of amygdala: activating opioid receptors through amygdala-periaqueductal gray pathway. Xu W; Lundeberg T; Wang YT; Li Y; Yu LC Neuroscience; 2003; 118(4):1015-22. PubMed ID: 12732246 [TBL] [Abstract][Full Text] [Related]
11. Dopamine receptor agonist rotigotine-loaded microspheres ameliorates sexual function deteriorated by fluoxetine in depression rats. Wang W; Zhang C; Fan Y; Yue S; Yang Y; Liu R; Zhang L; Wang T; Fu F ASN Neuro; 2021; 13():17590914211052862. PubMed ID: 34724850 [TBL] [Abstract][Full Text] [Related]
12. D2 receptor activation in distinct striatal neurons in comparison with D3 receptors. Sasa M; Ishihara K; Amano T; Matsubayashi H; Momiyama T; Todo N Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Apr; 17(2):97-100. PubMed ID: 9201730 [TBL] [Abstract][Full Text] [Related]
13. Three-month subchronic intramuscular toxicity study of rotigotine-loaded microspheres in Cynomolgus monkeys. Tian J; Du G; Ye L; Yu X; Zhang J; Wang H; Yu P; Fu F; Liu W; Li Y; Cen X; Guan X Food Chem Toxicol; 2013 Feb; 52():143-52. PubMed ID: 23165154 [TBL] [Abstract][Full Text] [Related]
14. Importance of the calcium content infused during microdialysis for the effects induced by D2 agonists on the release of dopamine in the striatum of the rat. Timmerman W; Westerink BH Neurosci Lett; 1991 Sep; 131(1):93-6. PubMed ID: 1686479 [TBL] [Abstract][Full Text] [Related]
15. Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors. Wood M; Dubois V; Scheller D; Gillard M Br J Pharmacol; 2015 Feb; 172(4):1124-35. PubMed ID: 25339241 [TBL] [Abstract][Full Text] [Related]
16. Enhanced antinociception with repeated microinjections of apomorphine into the periaqueductal gray of male and female rats. Schoo SM; Bobeck EN; Morgan MM Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):234-240. PubMed ID: 29256893 [TBL] [Abstract][Full Text] [Related]
17. Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain. Schiene K; De Vry J; Tzschentke TM J Pharmacol Exp Ther; 2011 Nov; 339(2):537-44. PubMed ID: 21816956 [TBL] [Abstract][Full Text] [Related]
18. Preclinical Evaluation of the Effects of Trazpiroben (TAK-906), a Novel, Potent Dopamine D Whiting RL; Choppin A; Luehr G; Jasper JR J Pharmacol Exp Ther; 2021 Oct; 379(1):85-95. PubMed ID: 34253646 [TBL] [Abstract][Full Text] [Related]
19. Antinociceptive activity of a synthetic curcuminoid analogue, 2,6-bis-(4-hydroxy-3-methoxybenzylidene)cyclohexanone, on nociception-induced models in mice. Ming-Tatt L; Khalivulla SI; Akhtar MN; Mohamad AS; Perimal EK; Khalid MH; Akira A; Lajis N; Israf DA; Sulaiman MR Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):275-82. PubMed ID: 21967232 [TBL] [Abstract][Full Text] [Related]
20. The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease. Scheller D; Ullmer C; Berkels R; Gwarek M; Lübbert H Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):73-86. PubMed ID: 18704368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]